Mentice ABOSTO:MNTC +0.38%76 OCF Yield % is 2.67 as of Jul. 06, 2026, which is 521% above its 10-year median of 0.43. GuruFocus rates OSTO:MNTC with a GF Score™ of 76/100 and a GF Value™ of kr26.00 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Mentice AB ranks better than 54.75% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Mentice AB's OCF Yield % or its related term are showing as below:
OSTO:MNTC'
s OCF Yield % Range Over the Past 10 Years
Min: -5.69 Med: 0.43 Max: 11.32
Current: 2.67
During the past 9 years, the highest OCF Yield % of Mentice AB was 11.32%. The lowest was -5.69%. And the median was 0.43%.
OSTO:MNTC's OCF Yield % is ranked better than 54.75% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 1.65
vs OSTO:MNTC: 2.67
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Mentice AB OCF Yield % Related Terms
Mentice AB OCF Yield % Historical Data
* Premium members only.
The historical data trend for Mentice AB's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:MNTC vs ABT, SYK, MDT: OCF Yield % Comparison
For the Medical Devices subindustry, Mentice AB's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mentice AB OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Mentice AB's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Mentice AB's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mentice AB (OSTO:MNTC) has a OCF Yield % of 2.67 as of Jul. 06, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Mentice AB and its competitors. This is 521% above median its historical median of 0.43. According to the industry distribution chart, Mentice AB ranks #386 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 45.3%.
Is Mentice AB's OCF Yield % too high?
Mentice AB's current OCF Yield % of 2.67 is 521% above median its 10-year median of 0.43. The Medical Devices & Instruments industry median OCF Yield % is 1.65. Mentice AB's value of 2.67 is 61.8% above this industry median. Based on the distribution chart, Mentice AB ranks #386 out of 853 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Mentice AB has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Mentice AB's OCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Mentice AB ranks #386 out of 853 companies for OCF Yield %. This puts Mentice AB in the upper half of its industry. The industry median OCF Yield % is 1.65. Mentice AB's value of 2.67 is 61.8% above this benchmark. While the company's 10-year median is 0.43 vs. the industry median of 1.65, Mentice AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.65, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mentice AB's current OCF Yield % of 2.67 is 61.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Mentice AB and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mentice AB's current OCF Yield % is 2.67, which is 521% above median its own 10-year median of 0.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mentice AB stock overvalued right now?
Based on GuruFocus' analysis, Mentice AB (OSTO:MNTC) is currently considered Possible Value Trap. The stock's GF Value™ is kr26.00, compared to a current price of kr13.05 — trading 49.8% below its estimated fair value. The current OCF Yield % is 2.67, which is 521% above median its 10-year median of 0.43 and 61.8% above the Medical Devices & Instruments industry median of 1.65. Mentice AB's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Mentice AB (OSTO:MNTC), the current OCF Yield % is 2.67 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mentice AB (OSTO:MNTC) Overvalued in 2026?
Based on GuruFocus' analysis, Mentice AB stock appears to be undervalued.
The current stock price of kr13.05 is trading 49.8% below its estimated GF Value™ of kr26.00.
GuruFocus considers Mentice AB to be Possible Value Trap.
Key valuation signals for OSTO:MNTC:
OCF Yield %: 2.67 (521% above median its 10-year median of 0.43)
GF Value™: kr26.00 vs. price of kr13.05 (49.8% below fair value)
Industry Position: 61.8% above the Medical Devices & Instruments median (#386 of 853)
No single metric tells the full story. See the OSTO:MNTC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mentice AB is a provider of software and hardware simulation solutions for image guided interventional therapies, offering proficiency based simulation solutions that help healthcare professionals acquire, retain, and enhance procedural skills, improving productivity and outcomes. Its solutions are scientifically validated and developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are covered. Mentice operates in two segments: Medical Device Industry (MDI), providing end-to-end solutions supporting development and launch of interventional therapies, and Healthcare Systems (HCS). Product areas include Mentice VIST, Physical Sim, Mentice Live, and Ankyras. It operates in EMEA, APAC, and the Americas.
76GF Score
Get the complete analysis for OSTO:MNTC
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:MNTC has been successfully added to your 
